Roche (RHHBY) has unveiled its latest innovation in diabetes care, paving its way into the continuous glucose monitoring (CGM) market, at the 17th International Conference on Advanced Technologies and Treatments for Diabetes in Florence, Italy. The new Accu-Chek SmartGuide solution for real-time CGM promises to revolutionize diabetes management with its predictive artificial intelligence (AI) capabilities, addressing critical unmet needs faced by individuals with diabetes. Roche is currently working toward ...